Not applicableUnknownNCT02814032What this trial is testingProteomics of Papillary Thyroid CarcinomaWho this might be right forPapillary Thyroid Carcinoma The Affiliated Hospital of Inner Mongolia Medical University 32
Testing effectiveness (Phase 2)Study completedNCT00057863What this trial is testingOxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical CancerWho this might be right forCervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma+3 more National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Study completedNCT00003065What this trial is testingTopotecan and Paclitaxel in Treating Patients With Recurrent or Metastatic Cancer of the CervixWho this might be right forCervical Cancer Herbert Irving Comprehensive Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT00096031What this trial is testingS0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction CancerWho this might be right forEsophageal Cancer SWOG Cancer Research Network 63
Early research (Phase 1)Looking for participantsNCT07284186What this trial is testingFirst-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid TumorsWho this might be right forEsophageal Squamous Cell CarcinomaGastric AdenocarcinomaGastric Squamous Cell Carcinoma+7 more Plexium, Inc. 155
Not applicableApproved For MarketingNCT04100694What this trial is testingEarly Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid TumorWho this might be right forNRG1 FusionPancreatic CancerNon Small Cell Lung Cancer+8 more Merus B.V.
Testing effectiveness (Phase 2)Ended earlyNCT03840967What this trial is testingA Study Evaluating Safety and Efficacy of Niraparib in Patients With Previously Treated Metastatic Esophageal/Gastroesophageal Junction/Proximal Gastric AdenocarcinomaWho this might be right forEsophageal CancerGastric CancerAdenocarcinoma Shadia Jalal, MD 14
Early research (Phase 1)Ended earlyNCT02543645What this trial is testingVarlilumab and Atezolizumab in Patients With Advanced CancerWho this might be right forCarcinoma, Renal CellKidney DiseasesKidney Neoplasms+11 more Celldex Therapeutics 18
Testing effectiveness (Phase 2)Ended earlyNCT01832857What this trial is testingPhase 2 Safety, Tolerability and Efficacy Study of CPI-613 in Cancer PatientsWho this might be right forCancer Cornerstone Pharmaceuticals 7
Post-approval studies (Phase 4)Study completedNCT01496313What this trial is testingTo Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid CancerWho this might be right forThyroid Cancer Sanofi 81
Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Looking for participantsNCT06805617What this trial is testingTrial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland CancersWho this might be right forSalivary Gland CancerAdvanced Salivary Gland CarcinomaMetastatic Salivary Gland Cancer+1 more Glenn J. Hanna 35
Not applicableStudy completedNCT00428220What this trial is testingA Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.Who this might be right forMetastatic Breast CancerAdvanced Breast CancerMetastatic Castration Resistant Prostate Cancer+9 more Pfizer 223
Large-scale testing (Phase 3)Study completedNCT00680901What this trial is testingLOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus LapatinibWho this might be right forNeoplasms, Gastrointestinal Tract Novartis Pharmaceuticals 545
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401What this trial is testingStudy Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment OptionsWho this might be right forSolid TumorsCNS Tumors Hoffmann-La Roche 69
Not applicableLooking for participantsNCT06967961What this trial is testingResearch of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic CancersWho this might be right forUrothelial CarcinomaRenal CancerProstate Adenocarcinoma+7 more Institut Claudius Regaud 450
Early research (Phase 1)Study completedNCT04430842What this trial is testingDose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072SWho this might be right forAstrocytomaBrain CancerBrain Metastases+20 more Quadriga Biosciences, Inc. 15
Not applicableActive Not RecruitingNCT04314401What this trial is testingNational Cancer Institute "Cancer Moonshot Biobank"Who this might be right forAcute Myeloid LeukemiaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8+26 more National Cancer Institute (NCI) 1,600
Testing effectiveness (Phase 2)Study completedNCT03409848What this trial is testingIpilimumab or FOLFOX in Combination With Nivolumab and Trastuzumab in HER2 Positive EsophagoGastric AdenocarcinomaWho this might be right forGastric CancerEsophageal CancerAdenocarcinoma Gastric+3 more AIO-Studien-gGmbH 97
Testing effectiveness (Phase 2)Study completedNCT00017212What this trial is testingDX-8951f in Treating Patients With Metastatic Stomach CancerWho this might be right forEsophageal CancerGastric Cancer Daiichi Sankyo